Leczyme: A New Candidate Drug for Cancer Therapy

First Page		Document Content
Biochemistry Pancreatic ribonuclease Lectin RNase P RNase H RNase L Angiogenin Concanavalin A Sialic acid Ribonucleases Biology Cell biology		Leczyme: A New Candidate Drug for Cancer Therapy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Download Document from Source Website File Size: 692,92 KB Share Document on Facebook

	SAMHD1 specifically restricts retroviruses through its RNase activity DocID: 1g2H0 - View Document
	RNase L releases a small RNA from HCV RNA that refolds into a potent PAMP KRISHNAMURTHY MALATHI,1,4 TAKESHI SAITO,2 NANNETTE CROCHET,2 DAVID J. BARTON,3 MICHAEL GALE JR.,2 and ROBERT H. SILVERMAN1 1 DocID: 10vJb - View Document
	Target Capture Transcription-Mediated Amplification Hybridization Protection Assay DocID: ZAEt - View Document
	Patterns of Variation Within Self-Incompatibility Loci Naoki Takebayashi,* Philip B. Brewer, Ed Newbigin, and Marcy K. Uyenoyama* *Department of Biology, Duke University; School of Botany, University of Melbourne, DocID: YW8S - View Document
	Proc. Natl. Acad. Sci. USA Vol. 74, No. 2, pp[removed], February 1977 Biochemistry Heteroduplex analysis of avian RNA tumor viruses DocID: RPsS - View Document